Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RespirAI Medical is an Israeli digital health company specializing in AI-driven solutions for chronic respiratory disease management. The company has developed a wearable platform that utilizes advanced algorithms to provide early warnings of exacerbations in patients with Chronic Obstructive Pulmonary Disease (COPD). By monitoring physiological parameters in real-time, the system enables proactive medical intervention, aiming to significantly reduce emergency room visits and hospital readmissions. RespirAI's technology is designed to be user-friendly and integrates into the existing clinical workflow to support both patients and healthcare providers. The platform was born out of clinical research at the Rabin Medical Center and is currently undergoing validation in clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RespirAI Medical.